Cardio Diagnostics Holdings is trading 5.7% down today at $1.69 amid broader weakness in the healthcare and small-cap biotech sectors.
- The decline appears to be aligned with sector-wide risk-off sentiment as there are no fresh company-specific headlines or fundamental developments driving the move.
- Recent positive news, including a July strategic agreement to launch the PrecisionCHD test in India, does not appear to be influencing today's price action.